PL377291A1 - Wytwarzanie IL-21 w gospodarzach prokariotycznych - Google Patents

Wytwarzanie IL-21 w gospodarzach prokariotycznych

Info

Publication number
PL377291A1
PL377291A1 PL377291A PL37729103A PL377291A1 PL 377291 A1 PL377291 A1 PL 377291A1 PL 377291 A PL377291 A PL 377291A PL 37729103 A PL37729103 A PL 37729103A PL 377291 A1 PL377291 A1 PL 377291A1
Authority
PL
Poland
Prior art keywords
coli
production
expression
vectors
prokaryotic hosts
Prior art date
Application number
PL377291A
Other languages
English (en)
Other versions
PL209009B1 (pl
Inventor
Douglas C. Covert
Chung Chang
Bruce L. Zamost
Hong Y. Liu
Jongh Karen S. De
Jeffrey D. Meyer
Susan D. Holderman
Original Assignee
Zymogenetics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics, Inc. filed Critical Zymogenetics, Inc.
Publication of PL377291A1 publication Critical patent/PL377291A1/pl
Publication of PL209009B1 publication Critical patent/PL209009B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
PL377291A 2002-12-13 2003-12-12 Wektor ekspresyjny do otrzymywania białka IL-21, komórka prokariotycznego gospodarza i sposób otrzymywania białek PL209009B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43344802P 2002-12-13 2002-12-13
US43345202P 2002-12-13 2002-12-13

Publications (2)

Publication Number Publication Date
PL377291A1 true PL377291A1 (pl) 2006-01-23
PL209009B1 PL209009B1 (pl) 2011-07-29

Family

ID=32600150

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377291A PL209009B1 (pl) 2002-12-13 2003-12-12 Wektor ekspresyjny do otrzymywania białka IL-21, komórka prokariotycznego gospodarza i sposób otrzymywania białek

Country Status (17)

Country Link
US (4) US7250274B2 (pl)
EP (1) EP1573006B1 (pl)
JP (1) JP4664684B2 (pl)
KR (1) KR101098897B1 (pl)
AT (1) ATE448298T1 (pl)
AU (1) AU2003302250B2 (pl)
BR (1) BR0317243A (pl)
CA (1) CA2507817C (pl)
DE (1) DE60330044D1 (pl)
DK (1) DK1573006T3 (pl)
ES (1) ES2334127T3 (pl)
IL (2) IL168697A (pl)
MX (1) MXPA05006117A (pl)
NO (1) NO334561B1 (pl)
PL (1) PL209009B1 (pl)
RU (1) RU2354703C2 (pl)
WO (1) WO2004055168A2 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6307024B1 (en) 1999-03-09 2001-10-23 Zymogenetics, Inc. Cytokine zalpha11 Ligand
WO2004112703A2 (en) * 2003-06-19 2004-12-29 Centocor, Inc. Interleukin-21 analogs
US20060228331A1 (en) * 2003-10-10 2006-10-12 Novo Nordisk A/S IL-21 Derivatives and variants
CN1867581B (zh) * 2003-10-10 2012-02-01 诺沃挪第克公司 Il-21衍生物
EP2641611A3 (en) 2003-10-17 2013-12-18 Novo Nordisk A/S Combination therapy
BRPI0511187A (pt) * 2004-05-20 2007-12-04 Zymogenetics Inc método para tratar cáncer em um indivìduo
CA2604222A1 (en) 2005-04-18 2006-10-26 Novo Nordisk A/S Il-21 variants
CA2608579C (en) * 2005-05-26 2019-09-10 Cytos Biotechnology Ag Scalable fermentation process
MX2007015039A (es) * 2005-06-06 2008-01-24 Novo Nordisk As Composiciones de il-21 estabilizadas.
US7858747B2 (en) * 2005-08-30 2010-12-28 Novo Nordisk A/S Expression of proteins in E.coli
EP2311995A1 (en) 2005-09-22 2011-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of using IL-21
CA2625208A1 (en) 2005-10-04 2007-04-12 Zymogenetics, Inc. Production and purification of il-29
WO2007111714A2 (en) 2005-11-28 2007-10-04 Zymogenetics, Inc. Il-21 antagonists
EP1966232A1 (en) * 2005-12-23 2008-09-10 Novo Nordisk A/S Purification of proteins using preparative reverse phase chromatography (rpc)
SG174013A1 (en) 2006-07-27 2011-09-29 Wyeth Corp High-cell density fed-batch fermentation process for producing recombinant protein
JP2010507382A (ja) 2006-10-26 2010-03-11 ノヴォ ノルディスク アクティーゼルスカブ Ｉｌ−２１変異体
US8211420B2 (en) 2006-12-21 2012-07-03 Novo Nordisk A/S Interleukin-21 variants with altered binding to the IL-21 receptor
CN101622269A (zh) * 2007-03-01 2010-01-06 诺沃-诺迪斯克有限公司 蛋白质在大肠杆菌中的表达
JP5358840B2 (ja) * 2007-11-24 2013-12-04 独立行政法人産業技術総合研究所 Ｇｆｐ（緑色蛍光蛋白質）の機能賦活・回復方法
US7883700B2 (en) 2007-12-07 2011-02-08 Zymogenetics, Inc. Anti-human IL-21 monoclonal antibodies
US9927440B2 (en) * 2009-11-25 2018-03-27 Duke University Protein engineering
WO2011149917A1 (en) * 2010-05-25 2011-12-01 Adlyfe, Inc. STABILIZED AMYLOID- β OLIGOMERS AND USES THEREOF
WO2013169693A1 (en) 2012-05-09 2013-11-14 Bristol-Myers Squibb Company Methods of treating cancer using an il-21 polypeptide and an anti-pd-1 antibody
JP6086378B2 (ja) * 2012-11-30 2017-03-01 国立大学法人お茶の水女子大学 組み換えヒト膵臓リパーゼの調製方法
WO2015178466A1 (ja) * 2014-05-21 2015-11-26 味の素株式会社 フィブロイン様タンパク質の製造法
RU2620073C2 (ru) * 2015-06-02 2017-05-22 Федеральное государственное бюджетное учреждение "Государственный научный центр Институт иммунологии" Федерального медико-биологического агентства России Оптимизированный ген, кодирующий рекомбинантный белок - аналог интерферона альфа-17 человека
RU2614264C2 (ru) * 2015-06-19 2017-03-24 Федеральное государственное бюджетное учреждение "Государственный научный центр Институт иммунологии" Федерального медико-биологического агентства России Оптимизированный ген, кодирующий рекомбинантный белок - аналог интерферона бета человека
RU2614124C9 (ru) * 2015-10-01 2020-04-22 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Оптимизированный ген, кодирующий рекомбинантный белок ипфiii
JP2017110001A (ja) * 2015-12-16 2017-06-22 株式会社 資生堂 タブレット型凍結乾燥化粧料
JP6404405B1 (ja) * 2017-06-14 2018-10-10 株式会社 資生堂 タブレット型凍結乾燥化粧料
US20210145705A1 (en) * 2017-06-19 2021-05-20 Shiseido Company, Ltd. Tablet-type freeze-dried cosmetic
WO2021074182A1 (en) * 2019-10-14 2021-04-22 Inbiose N.V. Production of bioproduct in a host cell
KR20230044394A (ko) * 2020-06-09 2023-04-04 아이코사백스, 인크. 바이러스 유사 입자를 제조하는 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4344697A (en) * 1996-10-04 1998-04-24 Amgen, Inc. Pharmaceutical compositions containing an mpl ligand
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
US6307024B1 (en) 1999-03-09 2001-10-23 Zymogenetics, Inc. Cytokine zalpha11 Ligand
KR100743640B1 (ko) * 1999-03-09 2007-07-27 지모제넥틱스, 인코포레이티드 신규한 사이토킨 ｚａｌｐｈａ 11 리간드
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
CA2481304A1 (en) 2002-03-27 2003-10-09 Patrick Hwu Method for treating cancer in humans
WO2003087320A2 (en) 2002-04-09 2003-10-23 Beth Israel Deaconess Medical Center, Inc. Antagonists of il-21 and modulation of il-21-mediated t cell responses
JP2006525223A (ja) 2002-10-11 2006-11-09 ノボ・ノルデイスク・エー／エス Ｉｌ２１の使用によるアレルギー症状の治療
CN1513993A (zh) 2002-12-31 2004-07-21 北京博泰迪生物工程科技开发有限公司 中国人基因组cDNA文库白细胞介素21的编码基因序列及其蛋白质的氨基酸序列
WO2004112703A2 (en) 2003-06-19 2004-12-29 Centocor, Inc. Interleukin-21 analogs
CA2545024A1 (en) 2003-11-24 2005-06-02 Novo Nordisk A/S Fusion proteins and methods of cleavage of such proteins

Also Published As

Publication number Publication date
AU2003302250A1 (en) 2004-07-09
PL209009B1 (pl) 2011-07-29
KR20050090393A (ko) 2005-09-13
US20070048798A1 (en) 2007-03-01
US7767199B2 (en) 2010-08-03
EP1573006A4 (en) 2006-06-14
IL198074A0 (en) 2011-08-01
NO334561B1 (no) 2014-04-07
KR101098897B1 (ko) 2011-12-26
US20060134754A1 (en) 2006-06-22
EP1573006A2 (en) 2005-09-14
NO20053385L (no) 2005-07-12
DE60330044D1 (de) 2009-12-24
WO2004055168A2 (en) 2004-07-01
JP2006509525A (ja) 2006-03-23
IL168697A (en) 2011-10-31
ES2334127T3 (es) 2010-03-05
US20070048842A1 (en) 2007-03-01
AU2003302250B2 (en) 2009-08-27
BR0317243A (pt) 2005-11-01
EP1573006B1 (en) 2009-11-11
US7622561B2 (en) 2009-11-24
RU2005117338A (ru) 2006-03-20
MXPA05006117A (es) 2005-09-30
CA2507817A1 (en) 2004-07-01
ATE448298T1 (de) 2009-11-15
CA2507817C (en) 2014-04-22
JP4664684B2 (ja) 2011-04-06
WO2004055168A3 (en) 2005-06-02
US7250274B2 (en) 2007-07-31
US20070048263A1 (en) 2007-03-01
RU2354703C2 (ru) 2009-05-10
DK1573006T3 (da) 2010-03-22
US7745176B2 (en) 2010-06-29

Similar Documents

Publication Publication Date Title
IL198074A0 (en) Il-21 production in prokaryotic hosts
PT1828239E (pt) Produção de fgf18 em hospedeiros procarióticos
Wu et al. CAMERS‐B: CRISPR/Cpf1 assisted multiple‐genes editing and regulation system for Bacillus subtilis
MY207355A (en) Codon-optimized acid lpha-glucosidase expression cassettes and methods of using same
AU2002311989A1 (en) Methods and materials for the production of organic products in cells of $i(candida) species
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
ES8607388A1 (es) Un metodo para preparar que tiene sustancialmente la misma secuencia de aminoacidos que la superoxido-dismutasa humana.
CN104059872A (zh) 高产n-乙酰氨基葡萄糖代谢工程菌及其构建方法和应用
WO2019136618A1 (zh) 高产尿苷的基因工程菌及其构建方法与应用
CN104894077B (zh) 烟酰胺腺嘌呤二核苷酸-细胞色素p450还原酶及其应用
DK1792982T3 (da) Codon-optimeret phosphatase og ekspression heraf i gær
CN103865944B (zh) 一种生产核黄素的大肠杆菌菌株及构建方法及用途
CN108330136A (zh) 一种构建产黄素单核苷酸的工程菌株的方法及其应用
Wang et al. CRISPR‐Cas9 mediated genome editing of Kluyveromyces marxianus for iterative, multiplexed gene disruption and pathway integration
WO1994000463A3 (en) Production of hyaluronic acid by transeformed microorganisms
Pilon et al. Ubiquitin fusion technology: bioprocessing of peptides
AU2002224554A1 (en) Cytochrome b5 gene and protein of candida tropicalis and methods relating thereto
EP0465132A2 (en) DNA and its use
AU4302000A (en) Genome sequence and polypeptides of pyrococcus (abissy), fragment and uses thereof
YU8402A (sh) Gen streptomyces avermitilis koji usmerava odnos b2:b1 avermektina
KR20230029344A (ko) 니코틴아미드 모노뉴클레오티드를 생산하는 재조합 대장균 및 이를 이용한 니코틴아미드 모노뉴클레오티드의 생산방법
EP1844135B1 (en) Escherichia strain capable of converting xmp to gmp and maintaining the inactivated state of gene(s) associated with gmp degradation and methods of using the same
BRPI0013119B8 (pt) molécula polinucleotídica isolada, vetor recombinante purificado, célula hospedeira procariótica e célula de streptomyces avermitilis mutada, método para obtenção de uma nova cepa de s. avermitilis e processo para produção de avermectinas
EP4253570A2 (en) Escherichia coli-based recombinant strain and construction method therefor and application thereof
CN105524955A (zh) 一种生物法制备可可碱的方法

Legal Events

Date Code Title Description
RECP Rectifications of patent specification